Document is current
Any future updates will be listed below
-
Authors
Lan, Nick S. R.
Dwivedi, Girish
Fegan, P. Gerry
Game, Fran
Hamilton, Emma J.
-
Funding
Funding for this research was provided by:
Western Australian Future Health Research and Innovation Fund
- License Information
-
More Information
Article History
Received: 14 September 2024
Accepted: 26 November 2024
First Online: 18 December 2024
Declarations
:
: NSRL has received research funding from Sanofi as part of a Clinical Fellowship in Endocrinology and Diabetes, education support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, CSL Seqirus, Eli Lilly, Novartis and Pfizer, speaker honoraria from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novartis and Sanofi, and has participated in advisory boards for Eli Lilly. PGF has received paid lectures from Novo Nordisk. GD reports paid lectures from AstraZeneca, Pfizer and Amgen and provides consultancy services and has equity interest in Artrya Ltd.
